redness and itching at tirzepatide injection site Tirzepatide-Induced Reaction Injection Site Reaction : r/tirzepatidecompound

Randomization was 1:1 between patients eligible for the administration of the target dose of subcutaneous Semaglutide 2.4 mg once a week and those who received a placebo

Reflux or heartburn (gastro-oesophageal reflux disease or GORD): Some patients may experience a burning sensation in the chest or throat caused by stomach acid moving up into the oesophagus

E.EekA.OyenW

Tirzepatide follows a structured dose-escalation protocol, starting at 2.5 mg weekly and increasing by 2.5 mg increments every four weeks as tolerated

Discontinuation typically results in appetite return and weight regain, so lower BMI patients should enter treatment with realistic expectations about duration and maintenance